Performance of factor IX extended half‐life product measurements in external quality control assessment programs-Reference-Cited by-同舟云学术

Performance of factor IX extended half‐life product measurements in external quality control assessment programs

Published:2020-06-10 Issue:8 Volume:18 Page:1874-1883
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Nederlof Angelique¹²,Kitchen Steve³,Meijer Piet⁴,Cnossen Marjon²,Ali Pour Nae⁵,Kershaw Geoffrey⁶,Jennings Ian³,Walker Isobel³,de Maat Moniek P. M.¹^ORCID

Affiliation:

1. Department of Haematology Erasmus University Medical Centre Rotterdam Rotterdam the Netherlands

2. Department of Paediatric Haematology Erasmus University Medical Centre Sophia Children’s Hospital Rotterdam the Netherlands

3. UKNEQAS BC Sheffield UK

4. ECAT Foundation Voorschoten the Netherlands

5. RCPAQAP St. Leonards Australia

6. Institute of Haematology Royal Prince Alfred Hospital Sydney Australia

Funder

Novo Nordisk

CSL Behring

Swedish Orphan Biovitrum

Pfizer

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14847

Reference30 articles.

1. Safety and Efficacy of Monoclonal Antibody Purified Factor IX Concentrate in Previously Untreated Patients with Hemophilia B

2. Genetic fusion to albumin improves the pharmacokinetic properties of factor IX

3. Prolonged activity of factor IX as a monomeric Fc fusion protein

4. Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide

5. Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers—for the External Quality Assurance in Thrombosis and Haemostasis Group;Seminars in Thrombosis and Hemostasis;2024-08-16

2. In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study;Journal of Thrombosis and Haemostasis;2023-11

3. High variability in Factor IX one‐stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system;International Journal of Laboratory Hematology;2023-09-13

4. Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments;Seminars in Thrombosis and Hemostasis;2022-12-06

5. External quality assessment for one‐stage and chromogenic factor IX assays in samples containing Alprolix (rFIXFc) or Idelvion (rIX‐FP) and evidence that UK National External Quality Assessment Scheme for blood coagulation samples are commutable with patient samples;International Journal of Laboratory Hematology;2022-01-17